Mallinckrodt uses cookies to improve and analyze site functionality. Some aspects of the site may not function properly without cookies enabled. To learn more about how we use cookies and how you can change your cookies settings, please read our Privacy Policy. By continuing to browse the site, you are agreeing to accept our use of cookies.
Therakos Information
Mallinckrodt plc announced on December 2, 2024 that it has completed the previously announced sale of its Therakos business to CVC Capital Partners Fund IX. Click here for more information. Please Click here to go to the Therakos Photopheresis website.
Visit Our Product Website